ICI works by targeting the programmed cell death 1 receptor (PD‐1), programmed cell death ligand 1 (PD‐L1), and cytotoxic T lymphocyte‐associated protein 4 (CTLA‐4), activating effective T cells, and killing tumor cells.6, 7. This evidence concerns the gene CD274 and neoplasm.